Nelson Van Denburg & Campbell Wealth Management Group LLC decreased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 13.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,977 shares of the pharmacy operator’s stock after selling 2,721 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC’s holdings in Walgreens Boots Alliance were worth $1,092,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of WBA. Greenleaf Trust grew its stake in shares of Walgreens Boots Alliance by 2.8% in the 1st quarter. Greenleaf Trust now owns 25,578 shares of the pharmacy operator’s stock valued at $1,618,000 after buying an additional 705 shares in the last quarter. FormulaFolio Investments LLC boosted its position in Walgreens Boots Alliance by 14.8% during the first quarter. FormulaFolio Investments LLC now owns 3,652 shares of the pharmacy operator’s stock worth $231,000 after purchasing an additional 471 shares during the period. Sentry Investment Management LLC boosted its position in Walgreens Boots Alliance by 873.7% during the first quarter. Sentry Investment Management LLC now owns 10,117 shares of the pharmacy operator’s stock worth $640,000 after purchasing an additional 9,078 shares during the period. TD Asset Management Inc. boosted its position in Walgreens Boots Alliance by 1.0% during the first quarter. TD Asset Management Inc. now owns 380,031 shares of the pharmacy operator’s stock worth $24,045,000 after purchasing an additional 3,902 shares during the period. Finally, SFE Investment Counsel boosted its position in Walgreens Boots Alliance by 9.5% during the first quarter. SFE Investment Counsel now owns 27,395 shares of the pharmacy operator’s stock worth $1,733,000 after purchasing an additional 2,381 shares during the period. Institutional investors own 63.84% of the company’s stock.
Shares of NASDAQ WBA opened at $52.94 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The firm has a market capitalization of $48.24 billion, a P/E ratio of 8.79, a PEG ratio of 1.07 and a beta of 0.77. Walgreens Boots Alliance Inc has a one year low of $51.79 and a one year high of $86.31.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be paid a $0.44 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.32%. Walgreens Boots Alliance’s payout ratio is 29.24%.
In related news, COO Ornella Barra acquired 18,000 shares of the company’s stock in a transaction on Wednesday, April 3rd. The stock was purchased at an average cost of $54.56 per share, for a total transaction of $982,080.00. Following the completion of the purchase, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the transaction, the chief accounting officer now owns 435,811 shares of the company’s stock, valued at $23,119,773.55. The disclosure for this sale can be found here. Corporate insiders own 15.73% of the company’s stock.
A number of equities research analysts have issued reports on the company. Pivotal Research decreased their target price on Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. UBS Group reduced their price objective on Walgreens Boots Alliance from $60.00 to $49.00 and set a “sell” rating for the company in a research report on Wednesday, April 3rd. Cowen reissued a “hold” rating and issued a $66.00 price objective on shares of Walgreens Boots Alliance in a research report on Sunday, March 31st. ValuEngine cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Wednesday, April 3rd. Finally, Guggenheim began coverage on Walgreens Boots Alliance in a research report on Thursday, April 18th. They issued a “neutral” rating and a $59.00 price objective for the company. Five research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $68.00.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance Inc (WBA) Holdings Cut by Nelson Van Denburg & Campbell Wealth Management Group LLC” was published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://dakotafinancialnews.com/2019/05/23/walgreens-boots-alliance-inc-wba-holdings-cut-by-nelson-van-denburg-campbell-wealth-management-group-llc.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: What does a market perform rating mean?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.